Organovo Holdings Announces Board and Executive Changes
Ticker: VIVS · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1497253
| Field | Detail |
|---|---|
| Company | Organovo Holdings, Inc. (VIVS) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $0.5368 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Organovo's board and exec comp just got a shake-up. New directors in, some execs out.
AI Summary
Organovo Holdings, Inc. announced on August 5, 2024, a change in its board of directors and executive compensation arrangements. Specifically, the company filed an 8-K detailing the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its key executives.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Numbers
- 001-35996 — SEC File Number (Identifies the company's filing history with the SEC.)
- 27-1488943 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Organovo Holdings, Inc. (company) — Registrant
- August 05, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 11555 Sorrento Valley Rd Suite 100 (address) — Principal Executive Offices
- San Diego, California (location) — Principal Executive Offices City and State
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates departures of certain officers and directors, but does not specify the exact roles in the provided text.
Who are the newly elected directors?
The filing mentions the election of new directors but does not name them in the provided text.
What are the key changes in the compensatory arrangements for certain officers?
The filing states there are updates to compensatory arrangements for certain officers, but the specifics are not detailed in the provided text.
What is the primary business of Organovo Holdings, Inc.?
Organovo Holdings, Inc. is in the business of Biological Products (No Diagnostic Substances), SIC code 2836.
When was Organovo Holdings, Inc. formerly known as Real Estate Restoration & Rental, Inc.?
The company's name change from Real Estate Restoration & Rental, Inc. occurred on July 22, 2010.
Filing Stats: 871 words · 3 min read · ~3 pages · Grade level 13.1 · Accepted 2024-08-09 16:05:08
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value ONVO The Nasdaq Stock Mar
- $0.5368 — ). The exercise price of the Options is $0.5368 per share. The Options were approved by
Filing Documents
- onvo-20240805.htm (8-K) — 41KB
- 0000950170-24-094736.txt ( ) — 152KB
- onvo-20240805.xsd (EX-101.SCH) — 24KB
- onvo-20240805_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Organovo Holdings, Inc. Date: August 9, 2024 By: /s/ Keith Murphy Name: Keith Murphy Title: Executive Chairman